Skip to main content
. 2015 Oct 7;2015(10):CD010081. doi: 10.1002/14651858.CD010081.pub2

Comparison 4. Infliximab versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 At least 50% decrease in HS Severity Index 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
2 Physician Global Assessment (judged to be clear, excellent, or good clinical response) 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected